[EN] DIARYLBENZOPYRAN DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS<br/>[FR] DERIVES DE DIARYLBENZOPYRANE UTILISES COMME INHIBITEURS DE CYCLOOXYGENASE-2
申请人:PACIFIC CORP
公开号:WO2000010993A1
公开(公告)日:2000-03-02
The diarylbenzopyran derivatives represented by general formula (I): wherein Y is an oxygen atom or a sulfur atom; R?1 and R2¿, identical to or different from each other, are independently a hydrogen atom, a halogen atom, a C¿1?-C6 lower alkyl group, a trifluromethyl group, an alkoxy group, a hydroxy group, a nitro group, a nitrile group, or a carboxyl group; R?3¿ is a group of a formula: S(O)nR5 wherein n is an integer of 0∩2, R5 is a hydrogen atom, a C¿1?-C6 lower alkyl group, or a group of a formula: NR?6R7¿ wherein R?6 and R7¿, identical to or different from each other, are independently a hydrogen atom, or a C¿1?-C6 lower alkyl group; R?4¿ is oxazolyl, benzo[b]thienyl, furanyl, thienyl, naphthyl, thiazolyl, indolyl, pyrolyl, benzofuranyl, benzodioxoyl, or a substituted group presented by structures (a), (b), (c) or (d) wherein R8 through R12 identical to or different from one another, are independently a hydrogen atom, a halogen atom, a C¿1?-C6 lower alkyl group, a trifluromethyl group, an alkoxy group, a hydroxy group, a hydroxyalkyl group, a nitro group, a group of a formula: S(O)nR?5¿, a group of a formula NR6R7, a trifluromethoxy group, a nitrile group, a carboxyl group, an acetyl group, or a formyl group wherein n, R?5, R6 and R7¿ have the same meaning as defined X and R3 above; and R13 is a hydrogen atom, a halogen atom, a C¿1?-C6 lower alkyl group, a trifluromethyl group, an alkoxy group, a hydroxy group, a trifluromethoxy group, a carboxyl group, or an acetyl group; or their pharmaceutically acceptable salts are disclosed. And also cyclooxygenase-2 inhibitor composition, which consists of an effective amount of a diarylbenzopyran derivative and pharmaceutically acceptable salts of diarylbenzopyran derivative and shows an excellent selective inhibition, is disclosed.
通式(I)所代表的二芳基苯并吡喃衍生物:其中Y是氧原子或硫原子;R1和R2,相同或不同,分别独立地是氢原子、卤素原子、C1-C6低烷基、三氟甲基基团、烷氧基、羟基、硝基、腈基或羧基;R3是公式S(O)nR5的基团,其中n是0-2的整数,R5是氢原子、C1-C6低烷基或公式NR6R7的基团,其中R6和R7,相同或不同,独立地是氢原子或C1-C6低烷基;R4是噁唑基、苯并[b]噻吩基、呋喃基、噻吩基、萘基、噻唑基、吲哚基、吡咯基、苯并呋喃基、苯并二氧杂环基或由结构(a)、(b)、(c)或(d)所示的取代基团,其中R8至R12相同或不同,独立地是氢原子、卤素原子、C1-C6低烷基、三氟甲基基团、烷氧基、羟基、羟基烷基基团、硝基、公式S(O)nR5的基团、公式NR6R7的基团、三氟甲氧基团、腈基、羧基、乙酰基或甲酰基,其中n、R5、R6和R7的含义与上述X和R3的定义相同;R13是氢原子、卤素原子、C1-C6低烷基、三氟甲基基团、烷氧基、羟基、三氟甲氧基团、羧基或乙酰基;或其药学上可接受的盐。还披露了环氧合酶-2抑制剂组合物,其由一种二芳基苯并吡喃衍生物的有效量和药学上可接受的二芳基苯并吡喃衍生物盐组成,并显示出优异的选择性抑制作用。